elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37067591-04236764-4E5A-4993-A598-DB60CD8F2B3F
Q37067591-04236764-4E5A-4993-A598-DB60CD8F2B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37067591-04236764-4E5A-4993-A598-DB60CD8F2B3F
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.
P5875
Q37067591-04236764-4E5A-4993-A598-DB60CD8F2B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37067591-04236764-4E5A-4993-A598-DB60CD8F2B3F
rank
NormalRank
type
BestRank
Statement
P5875
23478750
http://www.w3.org/2001/XMLSchema#string